BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 10544916)

  • 1. Allelic discrimination of factor V Leiden using a 5' nuclease assay.
    Happich D; Schwaab R; Hanfland P; Hoernschemeyer D
    Thromb Haemost; 1999 Oct; 82(4):1294-6. PubMed ID: 10544916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid genotyping of factor V Leiden mutation using single-tube bidirectional allele-specific amplification and automated ultrathin-layer agarose gel electrophoresis.
    Sasvari-Szekely M; Gerstner A; Ronai Z; Staub M; Guttman A
    Electrophoresis; 2000 Mar; 21(4):816-21. PubMed ID: 10733227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factor V Leiden genotyping using real-time fluorescent polymerase chain reaction.
    Sanders Sevall J
    Mol Cell Probes; 2000 Aug; 14(4):249-53. PubMed ID: 10970729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Semi-automated detection of the factor V mutation by allele specific amplification and capillary electrophoresis.
    van de Locht LT; Kuypers AW; Verbruggen BW; Linssen PC; Nováková IR; Mensink EJ
    Thromb Haemost; 1995 Nov; 74(5):1276-9. PubMed ID: 8607109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The polymerase chain reaction with sequence specific primers for the detection of the factor V mutation associated with activated protein C resistance.
    Kirschbaum NE; Foster PA
    Thromb Haemost; 1995 Sep; 74(3):874-8. PubMed ID: 8571314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allele-specific PCR amplification of factor V Leiden to identify patients at risk for thromboembolism.
    Blasczyk R; Wehling J; Ritter M; Neubauer A; Riess H
    Beitr Infusionsther Transfusionsmed; 1997; 34():236-41. PubMed ID: 9356679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Four-color multiplex 5' nuclease assay for the simultaneous detection of the factor V Leiden and the prothrombin G20210A mutations.
    Ugozzoli LA; Hamby K
    Mol Cell Probes; 2004 Jun; 18(3):161-6. PubMed ID: 15135449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic diagnosis of factor V Leiden using heteroduplex technology.
    Bowen DJ; Standen GR; Granville S; Bowley S; Wood NA; Bidwell J
    Thromb Haemost; 1997 Jan; 77(1):119-22. PubMed ID: 9031460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor V Leiden and factor V R2 allele: high-throughput analysis and association with venous thromboembolism.
    Benson JM; Ellingsen D; El-Jamil M; Jenkins M; Miller CH; Dilley A; Evatt BL; Hooper WC
    Thromb Haemost; 2001 Nov; 86(5):1188-92. PubMed ID: 11816705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double fluorescent-amplification refractory mutation detection (dF-ARMS) of the factor V Leiden and prothrombin mutations.
    Maher C; Crowley D; Cullen C; Wall C; Royston D; Fanning S
    Thromb Haemost; 1999 Jan; 81(1):76-80. PubMed ID: 9974379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simple and rapid detection of factor V Leiden by allele-specific PCR amplification.
    Blasczyk R; Ritter M; Thiede C; Wehling J; Hintz G; Neubauer A; Riess H
    Thromb Haemost; 1996 May; 75(5):757-9. PubMed ID: 8725719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of factor V Leiden from a drop of blood by PCR-SSCP.
    Corral J; Iniesta JA; González-Conejero R; Vicente V
    Thromb Haemost; 1996 Nov; 76(5):735-7. PubMed ID: 8950782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primer-engineered multiplex PCR-RFLP for detection of MTHFR C677T, prothrombin G20210A and factor V Leiden mutations.
    Koksal V; Baris I; Etlik O
    Exp Mol Pathol; 2007 Aug; 83(1):1-3. PubMed ID: 17275807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ARMS test for diagnosis of factor V Leiden mutation and allele frequencies in France.
    Bathelier C; Champenois T; Lucotte G
    Mol Cell Probes; 1998 Apr; 12(2):121-3. PubMed ID: 9633048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simple and reliable factor V genotyping by PNA-mediated PCR clamping.
    Behn M; Schuermann M
    Thromb Haemost; 1998 Apr; 79(4):773-7. PubMed ID: 9569191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical evaluation of a functional prothrombin time-based assay for identification of factor V Leiden carriers in a group of Italian patients with venous thrombosis.
    Gessoni G; Valverde S
    Blood Coagul Fibrinolysis; 2007 Oct; 18(7):603-10. PubMed ID: 17890946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor V gene A4070G mutation and the risk of cerebral veno-sinus thrombosis occurring during puerperium.
    Dindagur N; Kruthika-Vinod TP; Christopher R
    Thromb Res; 2007; 119(4):497-500. PubMed ID: 16781765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prevalence of factor V Leiden as a risk factor for venous thromboembolism in the population of North-Western Greece.
    Ioannou HV; Mitsis M; Eleftheriou A; Matsagas M; Nousias V; Rigopoulos C; Vartholomatos G; Kappas AM
    Int Angiol; 2000 Dec; 19(4):314-8. PubMed ID: 11305729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of factor V G1691A (Leiden) and prothrombin G20210A polymorphisms among apparently healthy Jordanians.
    Nusier MK; Radaideh AM; Ababneh NA; Qaqish BM; Alzoubi R; Khader Y; Mersa JY; Irshaid NM; El-Khateeb M
    Neuro Endocrinol Lett; 2007 Oct; 28(5):699-703. PubMed ID: 17984931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factor V Leiden, prothrombin gene mutation, and thrombosis risk in patients with antiphospholipid antibodies.
    Chopra N; Koren S; Greer WL; Fortin PR; Rauch J; Fortin I; Senécal JL; Docherty P; Hanly JG
    J Rheumatol; 2002 Aug; 29(8):1683-8. PubMed ID: 12180730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.